Actively Recruiting
Evaluating tDCS Brain-stimulation in Depression Using MRI
Led by University of California, Los Angeles · Updated on 2025-05-30
144
Participants Needed
1
Research Sites
236 weeks
Total Duration
On this page
Sponsors
U
University of California, Los Angeles
Lead Sponsor
N
National Institute of Mental Health (NIMH)
Collaborating Sponsor
AI-Summary
What this Trial Is About
Patients, physicians, and those who fund depression research are keenly interested in depression treatments that do not involve taking medications. One promising candidate treatment is transcranial direct current stimulation (tDCS), a low-cost technique that involves placing electrodes on specific scalp locations and using a 9-volt battery to cause a small amount of electricity to pass through parts of the brain. Depending on the direction of electrical flow, tDCS can make brain cells (neurons) more likely or less likely to generate their own electrical signals. When evaluated as a treatment, tDCS is typically done in daily sessions over a period of two weeks. One of the challenges of tDCS is to work out the best possible positioning of electrodes and direction of electricity flow to gradually cause lasting changes in brain activity in ways that might be expected to improve depression. To address this challenge, the investigators are using MRI to take pictures of the brain during tDCS. This data will help us better understand the short-term effects of tDCS in depression and help us learn how to customize future treatments to cause a lasting beneficial response. Patients with depression between the ages of 20-55 years are eligible to take part in this research. Potential participants will undergo: 1. An assessment to confirm eligibility. This will take place over a secure videoconference call lasting no more than 3 hours. 2. Two in-person study visits lasting 30 min and 2-1/2 hours respectively. In the first visit, the investigators will use the MRI to take a picture of the brain and head structure to determine appropriate locations for placing the tDCS electrodes at the start of the second visit. Following electrode placement, an MRI scan will be performed to take pictures of the brain during tDCS. Depending on the study arm, 1. Participants may receive 'active' or 'sham' tDCS. The 'sham' condition is identical to the 'active' tDCS in every way except that it involves minimal tDCS and is designed to help rule out effects unrelated to the administered tDCS electricity. 2. Participants may also be asked to perform a mental task during MRI. All participants will be compensated $150 + parking upon completion of all study-visits.
CONDITIONS
Official Title
Evaluating tDCS Brain-stimulation in Depression Using MRI
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Age between 20 to 55 years, inclusive
- All genders are eligible
- All races and ethnic groups are eligible
- Ability to provide informed consent
- Hamilton Rating Scale for Depression score of 17 or higher and less than 24, with or without anxiety symptoms
- Treatment naive or on a stable antidepressant regimen with no changes 6 weeks before and during the tDCS intervention
- Work at UCLA or live within 1 hour driving distance of UCLA
You will not qualify if you...
- Pregnancy
- Non-English speaking
- Substance use disorder within the last 12 months
- Neurological conditions with brain abnormalities (e.g., traumatic brain injury, recent stroke, tumor)
- Contraindications to tDCS (e.g., skin disease causing irritation)
- Conditions contraindicating scanning (e.g., metal implants, claustrophobia, breathing or movement disorders)
- Currently receiving any form of psychotherapy
- Change in antidepressant medication within 6 weeks before trial start
- Severe or treatment-resistant depression with HAMD scores over 24 or long-lasting major depressive episode or failure to respond to 2 or more antidepressant trials
- Neuromodulation therapy (ECT, rTMS, DBS, VNS, tDCS) within last 3 months
- Current or recent use of anticonvulsants, lithium, psychostimulants, dexamphetamine
- Current use of medications interfering with cortical excitability
- Diagnosis of schizophrenia or any type of dementia
- Bipolar I disorder
- Regular benzodiazepine use that cannot be stopped during the trial
- Depression related to serious medical illness
- Actively suicidal as defined by a score of 4 on item 3 of HAMD
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
University of California Los Angeles (UCLA)
Los Angeles, California, United States, 90095
Actively Recruiting
Research Team
M
Mayank A Jog, PhD
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
SINGLE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
BASIC_SCIENCE
Number of Arms
4
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here